Chemotherapy
Chemotherapy in the last 12 months.
| Condition group | Dataset | Coding system | Code value | Code description |
|---|---|---|---|---|
| chemo_group | SACT | Chemotherapy A | ABEMACICLIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ABEMACICLIB |
| chemo_group | SACT | Chemotherapy A | ABEMACICLIB + FULVESTRANT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ABEMACICLIB + FULVESTRANT |
| chemo_group | SACT | Chemotherapy A | ABIRATERONE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ABIRATERONE |
| chemo_group | SACT | Chemotherapy A | AFATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AFATINIB |
| chemo_group | SACT | Chemotherapy A | ALECTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ALECTINIB |
| chemo_group | SACT | Chemotherapy A | ANAGRELIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ANAGRELIDE |
| chemo_group | SACT | Chemotherapy A | ANAGRELIDE + HYDROXYCARBAMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ANAGRELIDE + HYDROXYCARBAMIDE |
| chemo_group | SACT | Chemotherapy A | APALUTAMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group APALUTAMIDE |
| chemo_group | SACT | Chemotherapy A | ATEZOLIZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ATEZOLIZUMAB |
| chemo_group | SACT | Chemotherapy A | ATEZOLIZUMAB + BEVACIZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ATEZOLIZUMAB + BEVACIZUMAB |
| chemo_group | SACT | Chemotherapy A | AVAPRITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AVAPRITINIB |
| chemo_group | SACT | Chemotherapy A | AVELUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AVELUMAB |
| chemo_group | SACT | Chemotherapy A | AXITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AXITINIB |
| chemo_group | SACT | Chemotherapy A | BCG | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BCG |
| chemo_group | SACT | Chemotherapy A | BEVACIZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BEVACIZUMAB |
| chemo_group | SACT | Chemotherapy A | BEXAROTENE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BEXAROTENE |
| chemo_group | SACT | Chemotherapy A | BRIGATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BRIGATINIB |
| chemo_group | SACT | Chemotherapy A | BUSULPHAN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BUSULPHAN |
| chemo_group | SACT | Chemotherapy A | CABOZANTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CABOZANTINIB |
| chemo_group | SACT | Chemotherapy A | CAP + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAP + RT |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE + CISPLATIN + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + CISPLATIN + RT |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE + GEMCITABINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + GEMCITABINE |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE + IRINOTECAN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + IRINOTECAN |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE + MITOMYCIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + MITOMYCIN |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE + MITOMYCIN + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + MITOMYCIN + RT |
| chemo_group | SACT | Chemotherapy A | CAPECITABINE + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + RT |
| chemo_group | SACT | Chemotherapy A | CEMIPLIMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CEMIPLIMAB |
| chemo_group | SACT | Chemotherapy A | CERITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CERITINIB |
| chemo_group | SACT | Chemotherapy A | CETUXIMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CETUXIMAB |
| chemo_group | SACT | Chemotherapy A | CISPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN |
| chemo_group | SACT | Chemotherapy A | CISPLATIN + FLUOROURACIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + FLUOROURACIL |
| chemo_group | SACT | Chemotherapy A | CISPLATIN + FLUOROURACIL + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + FLUOROURACIL + RT |
| chemo_group | SACT | Chemotherapy A | CISPLATIN + GEMCITABINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + GEMCITABINE |
| chemo_group | SACT | Chemotherapy A | CISPLATIN + PEMETREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + PEMETREXED |
| chemo_group | SACT | Chemotherapy A | CISPLATIN + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + RT |
| chemo_group | SACT | Chemotherapy A | COLUMBUS TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group COLUMBUS TRIAL |
| chemo_group | SACT | Chemotherapy A | COSMIC TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group COSMIC TRIAL |
| chemo_group | SACT | Chemotherapy A | CRIZOTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CRIZOTINIB |
| chemo_group | SACT | Chemotherapy A | DABRAFENIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DABRAFENIB |
| chemo_group | SACT | Chemotherapy A | DABRAFENIB + TRAMETINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DABRAFENIB + TRAMETINIB |
| chemo_group | SACT | Chemotherapy A | DACOMITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DACOMITINIB |
| chemo_group | SACT | Chemotherapy A | DENOSUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DENOSUMAB |
| chemo_group | SACT | Chemotherapy A | DICE TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DICE TRIAL |
| chemo_group | SACT | Chemotherapy A | DURVALUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DURVALUMAB |
| chemo_group | SACT | Chemotherapy A | ENZALUTAMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ENZALUTAMIDE |
| chemo_group | SACT | Chemotherapy A | EPIRUBICIN INTRAVESICULAR | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EPIRUBICIN INTRAVESICULAR |
| chemo_group | SACT | Chemotherapy A | ERLOTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ERLOTINIB |
| chemo_group | SACT | Chemotherapy A | EVEROLIMUS | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EVEROLIMUS |
| chemo_group | SACT | Chemotherapy A | EVEROLIMUS + LENVATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EVEROLIMUS + LENVATINIB |
| chemo_group | SACT | Chemotherapy A | FAKTION TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FAKTION TRIAL |
| chemo_group | SACT | Chemotherapy A | FLUOROURACIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FLUOROURACIL |
| chemo_group | SACT | Chemotherapy A | FLUOROURACIL + MITOMYCIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FLUOROURACIL + MITOMYCIN |
| chemo_group | SACT | Chemotherapy A | FLUOROURACIL + MITOMYCIN + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FLUOROURACIL + MITOMYCIN + RT |
| chemo_group | SACT | Chemotherapy A | FLUOROURACIL + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FLUOROURACIL + RT |
| chemo_group | SACT | Chemotherapy A | GEFITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group GEFITINIB |
| chemo_group | SACT | Chemotherapy A | HCX | ChemotherapyGroup Chemotherapy Treatment Benchmark Group HCX |
| chemo_group | SACT | Chemotherapy A | HYDROXYCARBAMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group HYDROXYCARBAMIDE |
| chemo_group | SACT | Chemotherapy A | ICON9 TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ICON9 TRIAL |
| chemo_group | SACT | Chemotherapy A | INTERIM TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group INTERIM TRIAL |
| chemo_group | SACT | Chemotherapy A | IPILIMUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IPILIMUMAB |
| chemo_group | SACT | Chemotherapy A | IPILIMUMAB + NIVOLUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IPILIMUMAB + NIVOLUMAB |
| chemo_group | SACT | Chemotherapy A | LANREOTIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LANREOTIDE |
| chemo_group | SACT | Chemotherapy A | LENVATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LENVATINIB |
| chemo_group | SACT | Chemotherapy A | LETROZOLE + RIBOCICLIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LETROZOLE + RIBOCICLIB |
| chemo_group | SACT | Chemotherapy A | LORLATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LORLATINIB |
| chemo_group | SACT | Chemotherapy A | MEDROXYPROGESTERONE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MEDROXYPROGESTERONE |
| chemo_group | SACT | Chemotherapy A | METHOTREXATE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group METHOTREXATE |
| chemo_group | SACT | Chemotherapy A | MITOMYCIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MITOMYCIN |
| chemo_group | SACT | Chemotherapy A | MITOMYCIN INTRAVESICULAR | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MITOMYCIN INTRAVESICULAR |
| chemo_group | SACT | Chemotherapy A | NERATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group NERATINIB |
| chemo_group | SACT | Chemotherapy A | NIRAPARIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group NIRAPARIB |
| chemo_group | SACT | Chemotherapy A | NIVOLUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group NIVOLUMAB |
| chemo_group | SACT | Chemotherapy A | OCTREOTIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OCTREOTIDE |
| chemo_group | SACT | Chemotherapy A | OLAPARIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OLAPARIB |
| chemo_group | SACT | Chemotherapy A | OSIMERTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OSIMERTINIB |
| chemo_group | SACT | Chemotherapy A | PALBOCICLIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PALBOCICLIB |
| chemo_group | SACT | Chemotherapy A | PAMIDRONATE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PAMIDRONATE |
| chemo_group | SACT | Chemotherapy A | PANITUMUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PANITUMUMAB |
| chemo_group | SACT | Chemotherapy A | PAZOPANIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PAZOPANIB |
| chemo_group | SACT | Chemotherapy A | PEMBROLIZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PEMBROLIZUMAB |
| chemo_group | SACT | Chemotherapy A | PEMETREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PEMETREXED |
| chemo_group | SACT | Chemotherapy A | PERTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PERTUZUMAB |
| chemo_group | SACT | Chemotherapy A | PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy A | PONATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PONATINIB |
| chemo_group | SACT | Chemotherapy A | PRISM TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PRISM TRIAL |
| chemo_group | SACT | Chemotherapy A | REGORAFENIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group REGORAFENIB |
| chemo_group | SACT | Chemotherapy A | RIBOCICLIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group RIBOCICLIB |
| chemo_group | SACT | Chemotherapy A | SORAFENIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group SORAFENIB |
| chemo_group | SACT | Chemotherapy A | STAR TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group STAR TRIAL |
| chemo_group | SACT | Chemotherapy A | SUNITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group SUNITINIB |
| chemo_group | SACT | Chemotherapy A | TIVOZANIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TIVOZANIB |
| chemo_group | SACT | Chemotherapy A | TRAMETINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TRAMETINIB |
| chemo_group | SACT | Chemotherapy A | TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy A | UNIRAD TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group UNIRAD TRIAL |
| chemo_group | SACT | Chemotherapy A | VINORELBINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group VINORELBINE |
| chemo_group | SACT | Chemotherapy A | VISMODEGIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group VISMODEGIB |
| chemo_group | SACT | Chemotherapy A | ZOLEDRONIC ACID | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ZOLEDRONIC ACID |
| chemo_group | SACT | Chemotherapy B | ABVD | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ABVD |
| chemo_group | SACT | Chemotherapy B | AC | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AC |
| chemo_group | SACT | Chemotherapy B | ACALABRUTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ACALABRUTINIB |
| chemo_group | SACT | Chemotherapy B | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE |
| chemo_group | SACT | Chemotherapy B | ATEZOLIZUMAB + NAB PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ATEZOLIZUMAB + NAB PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | BENDAMUSTINE + RITUXIMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BENDAMUSTINE + RITUXIMAB |
| chemo_group | SACT | Chemotherapy B | BEVACIZUMAB + CARBO + PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BEVACIZUMAB + CARBO + PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | BINIMETINIB + ENCORAFENIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BINIMETINIB + ENCORAFENIB |
| chemo_group | SACT | Chemotherapy B | BLEOMYCIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BLEOMYCIN |
| chemo_group | SACT | Chemotherapy B | BOP | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BOP |
| chemo_group | SACT | Chemotherapy B | BORTEZOMIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BORTEZOMIB |
| chemo_group | SACT | Chemotherapy B | BORTEZOMIB + DARATUMUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BORTEZOMIB + DARATUMUMAB |
| chemo_group | SACT | Chemotherapy B | BORTEZOMIB + THALIDOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BORTEZOMIB + THALIDOMIDE |
| chemo_group | SACT | Chemotherapy B | BOSUTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BOSUTINIB |
| chemo_group | SACT | Chemotherapy B | CABAZITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CABAZITAXEL |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + CARBOPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + CARBOPLATIN |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + CARBOPLATIN + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + CARBOPLATIN + RT |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + CETUXIMAB + IRINOTECAN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + CETUXIMAB + IRINOTECAN |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + CISPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + CISPLATIN |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + OXALIPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + OXALIPLATIN |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + STREPTOZOCIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + STREPTOZOCIN |
| chemo_group | SACT | Chemotherapy B | CAPECITABINE + TEMOZOLOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAPECITABINE + TEMOZOLOMIDE |
| chemo_group | SACT | Chemotherapy B | CARBO + FLUOROURACIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBO + FLUOROURACIL |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + CETUXIMAB + FU | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + CETUXIMAB + FU |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + DOCETAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + DOCETAXEL |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + DOCETAXEL + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + ETOPOSIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + ETOPOSIDE |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + LIPOSOMAL DOX | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + LIPOSOMAL DOX |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + PACLITAXEL + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + PACLITAXEL + RT |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + PEMETREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + PEMETREXED |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + RT |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + VINORELBINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + VINORELBINE |
| chemo_group | SACT | Chemotherapy B | CARBOPLATIN + VINORELBINE + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CARBOPLATIN + VINORELBINE + RT |
| chemo_group | SACT | Chemotherapy B | CAV | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CAV |
| chemo_group | SACT | Chemotherapy B | CETUXIMAB + IRINOTECAN + MDG | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CETUXIMAB + IRINOTECAN + MDG |
| chemo_group | SACT | Chemotherapy B | CETUXIMAB + OXALIPLATIN + MDG | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CETUXIMAB + OXALIPLATIN + MDG |
| chemo_group | SACT | Chemotherapy B | CHLORAMBUCIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CHLORAMBUCIL |
| chemo_group | SACT | Chemotherapy B | CHOP | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CHOP |
| chemo_group | SACT | Chemotherapy B | CHOP R | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CHOP R |
| chemo_group | SACT | Chemotherapy B | CISPLATIN + DOCETAXEL + FLUOROURACIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + DOCETAXEL + FLUOROURACIL |
| chemo_group | SACT | Chemotherapy B | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + DOX + ETOPOSIDE + MITOTANE |
| chemo_group | SACT | Chemotherapy B | CISPLATIN + ETOPOSIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + ETOPOSIDE |
| chemo_group | SACT | Chemotherapy B | CISPLATIN + ETOPOSIDE + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + ETOPOSIDE + RT |
| chemo_group | SACT | Chemotherapy B | CISPLATIN + PEMBROLIZUMAB + PEMETREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + PEMBROLIZUMAB + PEMETREXED |
| chemo_group | SACT | Chemotherapy B | CISPLATIN + VINORELBINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CISPLATIN + VINORELBINE |
| chemo_group | SACT | Chemotherapy B | CLL210 TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CLL210 TRIAL |
| chemo_group | SACT | Chemotherapy B | COMPARE TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group COMPARE TRIAL |
| chemo_group | SACT | Chemotherapy B | CTD | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CTD |
| chemo_group | SACT | Chemotherapy B | CVD | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CVD |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + DOCETAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + DOCETAXEL |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + DOCETAXEL + DOXORUBICIN + PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + DOCETAXEL + DOXORUBICIN + PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + DOXORUBICIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + DOXORUBICIN |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + LENALIDOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| chemo_group | SACT | Chemotherapy B | CYCLOPHOSPHAMIDE + RITUXIMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE + RITUXIMAB |
| chemo_group | SACT | Chemotherapy B | DACTINOMYCIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DACTINOMYCIN |
| chemo_group | SACT | Chemotherapy B | DARATUMUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DARATUMUMAB |
| chemo_group | SACT | Chemotherapy B | DASATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DASATINIB |
| chemo_group | SACT | Chemotherapy B | DOCETAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOCETAXEL |
| chemo_group | SACT | Chemotherapy B | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOCETAXEL + FLUOROURACIL + OXALIPLATIN |
| chemo_group | SACT | Chemotherapy B | DOCETAXEL + GEMCITABINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOCETAXEL + GEMCITABINE |
| chemo_group | SACT | Chemotherapy B | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | DOCETAXEL + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOCETAXEL + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | DOXORUBICIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOXORUBICIN |
| chemo_group | SACT | Chemotherapy B | DOXORUBICIN EMBOLISATION | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DOXORUBICIN EMBOLISATION |
| chemo_group | SACT | Chemotherapy B | EC | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EC |
| chemo_group | SACT | Chemotherapy B | EC + DOCETAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EC + DOCETAXEL |
| chemo_group | SACT | Chemotherapy B | EC + DOCETAXEL + PERTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EC + DOCETAXEL + PERTUZUMAB |
| chemo_group | SACT | Chemotherapy B | EC + DOCETAXEL + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EC + DOCETAXEL + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | EC + PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EC + PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | ECX | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ECX |
| chemo_group | SACT | Chemotherapy B | EMA/CO | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EMA/CO |
| chemo_group | SACT | Chemotherapy B | ENRICH TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ENRICH TRIAL |
| chemo_group | SACT | Chemotherapy B | EOX | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EOX |
| chemo_group | SACT | Chemotherapy B | EP | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EP |
| chemo_group | SACT | Chemotherapy B | EPIRUBICIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group EPIRUBICIN |
| chemo_group | SACT | Chemotherapy B | ERIBULIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ERIBULIN |
| chemo_group | SACT | Chemotherapy B | ETOPOSIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ETOPOSIDE |
| chemo_group | SACT | Chemotherapy B | FEC | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FEC |
| chemo_group | SACT | Chemotherapy B | FEC + DOCETAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FEC + DOCETAXEL |
| chemo_group | SACT | Chemotherapy B | FEC + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FEC + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | FEC + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FEC + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| chemo_group | SACT | Chemotherapy B | FOCUS4 TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FOCUS4 TRIAL |
| chemo_group | SACT | Chemotherapy B | GEMCARBO | ChemotherapyGroup Chemotherapy Treatment Benchmark Group GEMCARBO |
| chemo_group | SACT | Chemotherapy B | GEMCITABINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group GEMCITABINE |
| chemo_group | SACT | Chemotherapy B | GEMCITABINE + NAB-PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group GEMCITABINE + NAB-PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | GEMCITABINE + PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group GEMCITABINE + PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | GEMCITABINE + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group GEMCITABINE + RT |
| chemo_group | SACT | Chemotherapy B | IBRUTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IBRUTINIB |
| chemo_group | SACT | Chemotherapy B | IDELALISIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IDELALISIB |
| chemo_group | SACT | Chemotherapy B | IDELALISIB + RITUXIMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IDELALISIB + RITUXIMAB |
| chemo_group | SACT | Chemotherapy B | IMATINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IMATINIB |
| chemo_group | SACT | Chemotherapy B | IRINOTECAN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IRINOTECAN |
| chemo_group | SACT | Chemotherapy B | IRINOTECAN + MDG | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IRINOTECAN + MDG |
| chemo_group | SACT | Chemotherapy B | IRINOTECAN + MDG + PANITUMUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IRINOTECAN + MDG + PANITUMUMAB |
| chemo_group | SACT | Chemotherapy B | IXAZOMIB + LENALIDOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group IXAZOMIB + LENALIDOMIDE |
| chemo_group | SACT | Chemotherapy B | LENALIDOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LENALIDOMIDE |
| chemo_group | SACT | Chemotherapy B | LIPOSOMAL DOXORUBICIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LIPOSOMAL DOXORUBICIN |
| chemo_group | SACT | Chemotherapy B | LOMUSTINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LOMUSTINE |
| chemo_group | SACT | Chemotherapy B | LUTETIUM-177 | ChemotherapyGroup Chemotherapy Treatment Benchmark Group LUTETIUM-177 |
| chemo_group | SACT | Chemotherapy B | MELPHALAN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MELPHALAN |
| chemo_group | SACT | Chemotherapy B | METAPHER TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group METAPHER TRIAL |
| chemo_group | SACT | Chemotherapy B | MIC | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MIC |
| chemo_group | SACT | Chemotherapy B | MITOTANE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MITOTANE |
| chemo_group | SACT | Chemotherapy B | MMM | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MMM |
| chemo_group | SACT | Chemotherapy B | MPV | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MPV |
| chemo_group | SACT | Chemotherapy B | MVAC | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MVAC |
| chemo_group | SACT | Chemotherapy B | MYELOMA XI TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MYELOMA XI TRIAL |
| chemo_group | SACT | Chemotherapy B | NAB-PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group NAB-PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | NILOTINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group NILOTINIB |
| chemo_group | SACT | Chemotherapy B | OXALIPLATIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OXALIPLATIN |
| chemo_group | SACT | Chemotherapy B | OXALIPLATIN + MDG | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OXALIPLATIN + MDG |
| chemo_group | SACT | Chemotherapy B | OXALIPLATIN + MDG + PANITUMUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OXALIPLATIN + MDG + PANITUMUMAB |
| chemo_group | SACT | Chemotherapy B | OXALIPLATIN + RALTITREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group OXALIPLATIN + RALTITREXED |
| chemo_group | SACT | Chemotherapy B | PACLITAXEL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PACLITAXEL |
| chemo_group | SACT | Chemotherapy B | PACLITAXEL + PERTUZUMAB + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PACLITAXEL + PERTUZUMAB + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | PACLITAXEL + TRASTUZUMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PACLITAXEL + TRASTUZUMAB |
| chemo_group | SACT | Chemotherapy B | PARTNER TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PARTNER TRIAL |
| chemo_group | SACT | Chemotherapy B | PCV | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PCV |
| chemo_group | SACT | Chemotherapy B | PEG INTERFERON | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PEG INTERFERON |
| chemo_group | SACT | Chemotherapy B | PLATO TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PLATO TRIAL |
| chemo_group | SACT | Chemotherapy B | POMALIDOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group POMALIDOMIDE |
| chemo_group | SACT | Chemotherapy B | PROCARBAZINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group PROCARBAZINE |
| chemo_group | SACT | Chemotherapy B | RALTITREXED | ChemotherapyGroup Chemotherapy Treatment Benchmark Group RALTITREXED |
| chemo_group | SACT | Chemotherapy B | RITUXIMAB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group RITUXIMAB |
| chemo_group | SACT | Chemotherapy B | RUXOLITINIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group RUXOLITINIB |
| chemo_group | SACT | Chemotherapy B | STAMPEDE TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group STAMPEDE TRIAL |
| chemo_group | SACT | Chemotherapy B | TEMOZOLOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TEMOZOLOMIDE |
| chemo_group | SACT | Chemotherapy B | TEMOZOLOMIDE + RT | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TEMOZOLOMIDE + RT |
| chemo_group | SACT | Chemotherapy B | THALIDOMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group THALIDOMIDE |
| chemo_group | SACT | Chemotherapy B | TRABECTEDIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TRABECTEDIN |
| chemo_group | SACT | Chemotherapy B | TRASTUZUMAB EMTANSINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TRASTUZUMAB EMTANSINE |
| chemo_group | SACT | Chemotherapy B | VEMURAFENIB | ChemotherapyGroup Chemotherapy Treatment Benchmark Group VEMURAFENIB |
| chemo_group | SACT | Chemotherapy B | VENETOCLAX | ChemotherapyGroup Chemotherapy Treatment Benchmark Group VENETOCLAX |
| chemo_group | SACT | Chemotherapy C | ALL PH+VE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ALL PH+VE |
| chemo_group | SACT | Chemotherapy C | ARSENIC TRIOXIDE + ATRA | ChemotherapyGroup Chemotherapy Treatment Benchmark Group ARSENIC TRIOXIDE + ATRA |
| chemo_group | SACT | Chemotherapy C | AZACITIDINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AZACITIDINE |
| chemo_group | SACT | Chemotherapy C | AZACITIDINE + VENETOCLAX | ChemotherapyGroup Chemotherapy Treatment Benchmark Group AZACITIDINE + VENETOCLAX |
| chemo_group | SACT | Chemotherapy C | BEP | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BEP |
| chemo_group | SACT | Chemotherapy C | BLEOMYCIN + CISPLATIN + ETOPOSIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| chemo_group | SACT | Chemotherapy C | CHOP R + METHOTREXATE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CHOP R + METHOTREXATE |
| chemo_group | SACT | Chemotherapy C | CYCLOPHOSPHAMIDE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYCLOPHOSPHAMIDE |
| chemo_group | SACT | Chemotherapy C | CYTARABINE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYTARABINE |
| chemo_group | SACT | Chemotherapy C | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | ChemotherapyGroup Chemotherapy Treatment Benchmark Group CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN |
| chemo_group | SACT | Chemotherapy C | DA | ChemotherapyGroup Chemotherapy Treatment Benchmark Group DA |
| chemo_group | SACT | Chemotherapy C | FLAIR TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group FLAIR TRIAL |
| chemo_group | SACT | Chemotherapy C | MATRIX TRIAL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group MATRIX TRIAL |
| chemo_group | SACT | Chemotherapy C | METHOTREXATE HIGH DOSE | ChemotherapyGroup Chemotherapy Treatment Benchmark Group METHOTREXATE HIGH DOSE |
| chemo_group | SACT | Chemotherapy C | R IVAC | ChemotherapyGroup Chemotherapy Treatment Benchmark Group R IVAC |
| chemo_group | SACT | Chemotherapy C | RADIUM 223 | ChemotherapyGroup Chemotherapy Treatment Benchmark Group RADIUM 223 |
| chemo_group | SACT | Chemotherapy C | TRIFLURIDINE + TIPIRACIL | ChemotherapyGroup Chemotherapy Treatment Benchmark Group TRIFLURIDINE + TIPIRACIL |
| chemo_group | SACT | Chemotherapy C | UKALL2014 | ChemotherapyGroup Chemotherapy Treatment Benchmark Group UKALL2014 |
